Clinical Trial Update: Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 safety study of PRTX-100 combined with methotrexate or leflunomide for active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide (Leflunomide)
• METHOTREXATE (METHOTREXATE)
• PRTX-100

Snippet

Sponsor: Protalex, Inc. | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED